2-(4-(Trifluoromethyl)phenyl)-1H-benzo[d]imidazole

Catalog No. :
ACAQWT961
CAS No. :
400073-79-2
Molecular Formula :
C14H9F3N2
Molecular Weight :
262.23

IUPAC Name:2-(4-(trifluoromethyl)phenyl)-1H-benzo[d]imidazole

2-(4-(Trifluoromethyl)phenyl)-1H-benzo[d]imidazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$225.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-(Trifluoromethyl)phenyl)-1H-benzo[d]imidazole
IUPAC Name2-(4-(trifluoromethyl)phenyl)-1H-benzo[d]imidazole
MDL No.MFCD02656542
Molecular FormulaC14H9F3N2
Molecular Weight262.23
SMILESFC(C1=CC=C(C2=NC3=CC=CC=C3N2)C=C1)(F)F
InChI KeyBZLJTCPNDNUPHL-UHFFFAOYSA-N
SynonymOTAVA-BB 1325788;4-(1H-Benzimidazol-2-yl)benzotrifluoride, 1-(1H-Benzimidazol-2-yl)-4-(trifluoromethyl)benzene;2-[4-(TRIFLUOROMETHYL)PHENYL]-1H-1,3-BENZIMIDAZOLE;1H-Benzimidazole, 2-[4-(trifluoromethyl)phenyl]-;2-(4-(Trifluoromethyl)phenyl)-1h-benzo[d]imidazole
CAS No.400073-79-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACAQWT961 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEASN653 route compound structure diagram
    ACEASN65325832-58-0 In Stock
  4. Then
  5. ACAQWT961 route product structure diagram
    ACAQWT961400073-79-2
Inquiry

2. ACAQWT961 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGYWK541 route compound structure diagram
    ACGYWK541455-19-6 In Stock
  4. Then
  5. ACAQWT961 route product structure diagram
    ACAQWT961400073-79-2
Inquiry

Comments (0)